An interventional study of High Intensity Walking and Casual Speed Walking in Frailty, sponsored by Northwestern University. Completed at 1 site in United States. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-02.
Sponsored by Northwestern University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 185 studies in Frailty with a site in United States — 48 open to participants now, 61 under way, 1 of them phase 3. Frailty · United States.
Among the 185 studies in Frailty with a site in United States, this one is the 14th largest by enrollment of the 142 interventional ones that give a count, is one of 19 that started in 2018, is one of 93 with no phase, and was the 64th registered.
1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.
Browse Frailty studies →48 of the 185 studies in Frailty with a site in United States are open now. Recruiting first, the newest first:
University of Maryland, Baltimore · Sites in United States
Ages 55+
University of California, San Francisco · Sites in United States
Ages 18–75
Longevity Metrics, Inc. · Sites in United States
Ages 18+ · Healthy volunteers
William Brandenburg, MD · Sites in United States
Ages 18+ · Healthy volunteers
Longevity Metrics, Inc. · Sites in United States
Ages 18+ · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.
This study: 60 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
185 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 16 · Phase 2 32 · Phase 3 5 · Phase 4 5
First in 2001; this study’s year is marked. 19 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 165 is above the median of 83 across 772 interventional studies indexed under Frailty.
Median enrollment 42 across the 142 interventional studies, 128 across the 42 observational. Of the 113 that completed or were terminated, 43 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 185 have an industry lead sponsor. The 10 most frequent:
Northwestern University is the lead sponsor of 1,424 studies on the registry; 199 are open to participants now.
Of its 105 completed or terminated interventional studies of FDA-regulated products, 78 (74%) have results posted.
Northwestern University has 5 studies filed under Frailty — fewer than ten, so there is no comparison to draw.
24 of the studies in Frailty with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05422534Phase 3Vanderbilt University Medical CenterCoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease | 2027-06-20 |
| NCT03675724Mayo ClinicAlleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Adults | 2026-11 |
| NCT03430037Mayo ClinicAlleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women | 2026-11 |
| NCT07220512Wake Forest University Health SciencesThe Better, Harder, Faster, Stronger Study | 2026-11 |
| NCT06404970VA Office of Research and DevelopmentA Partnered Evaluation to Improve the Identification and Management of Functional Impairment and Frailty Among Older Veterans in Primary Care Settings | 2026-11-30 |
Add all 24 to your calendar (.ics) → With an account.
Among the 185 studies in Frailty with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to test the effect of walking intensity on both frailty category (i.e., frail, pre-frail, and nonfrail) and frailty score as a continuous outcome on the SHARE-FI (frailty instrument). As well as test the effect of walking intensity on mobility, physical function, balance, and total Physical Activity.
Frailty impacts up to 60% of older adults and is a leading cause of dependency among older adults. Frail older adults experience physical problems such as balance difficulties, weakness, decreased endurance, and reduced walking speed that increase risk for falls, hospitalizations, institutionalization, and death. Physical activity has multi-system health benefits and is the most recommended frailty management intervention, but guidelines regarding the specific intensity of physical activity remain unclear. High intensity physical activity is an established and safe therapeutic approach in other populations, but it is unclear as to the extent to which high intensity activity can reduce or reverse frailty. This cluster-randomized study will compare a high intensity walking (HIW) intervention to a self-selected, casual speed walking (CSW) intervention implemented within retirement communities for pre-frail and frail older adults. Investigators will randomize 10 retirement communities with 20 participants at each site (200 total participants) to either a 4-month HIW or CSW intervention. All participants will receive 48, individually supervised overground walking sessions occurring within their retirement community. At the beginning and end of the study, investigators will measure participants' frailty, mobility, physical functioning, balance, and total physical activity measured via an ActivPal accelerometer worn for a 1-week observation period to compare which treatment strategy, HIW or CSW, worked better to reduce frailty (aim #1). Investigators will use the SHARE-Frailty Instrument to evaluate frailty as both a categorical (e.g. non-frail, pre-frail, or frail) and a continuous outcome. This approach will allow investigators to determine how participants move between frailty categories as well as within frailty categories in response to intervention. In aim #2, investigators will determine the effect of walking intensity on mobility, physical functioning, balance, and total physical activity. Investigators hypothesize that HIW participants will show decreased frailty and improved mobility, physical functioning, balance, and physical activity at 4 months. Currently, the optimal physical activity guidelines for older adults with frailty are uncertain. Results from this study will provide important knowledge to inform activity guidelines for older adults with frailty and information on a transformative approach to reducing frailty, improving function, and increasing physical activity among a growing segment of the older adults population.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
> 60 years of age with pre-frailty or frailty as determined on the SHARE-FI.
Exclusion Criteria:
Uncontrolled cardiovascular, metabolic, renal, or respiratory disease that limits exercise participation (e.g., previous heart attack within 3 months of enrollment or uncontrolled diabetes)
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HIW (70-80% HRmax)
Behavioral: High Intensity Walking
Self selected pace
Behavioral: Casual Speed Walking
70-80% HRmax
Self selected pace
Survey of Health, Ageing, and Retirement in Europe-Frailty Instrument (SHARE-FI)
Survey of Health Among Retired Europeans - Frailty Index (SHARE-FI) which assesses fatigue, appetite, weakness, walking difficulties, and low physical activity. There is not a max and min score; Higher scores indicate greater severity of frailty. Classification for Women: Non-frail: ≤0.315 Pre-frail: 0.316-2.130 Frail: ≥2.131 Classification for Men" Non-frail: ≤1.210 Pre-frail: 1.211-3.005 Frail: ≥3.006
Time frame: Baseline and four months
Improved Mobility as Measured by Gait Speed
Gait speed was measured independently as a continuous measure in meters per second (m/s). Participants completed two trials over 10 meters at both self-selected usual speed ("walk at your normal comfortable pace") and fastest-possible speed ("as fast as you safely can"), and the two trials were averaged for analysis.
Time frame: Baseline and four months
Improved Physical Function on the Short Physical Performance Battery
The Short Physical Performance Battery is a scale to assess overall functional status and physical performance Min score = 0 Max score = 12 Higher scores = better physical function
Time frame: Baseline and four months
Improved Balance as Measured by the Berg Balance Scale
The Berg Balance Scale is a valid and reliable 14 item tool to evaluate static and dynamic balance among older adults. Minimum Score: 0 to Maximum Score: 56 Score of \< 45 indicates individuals may be at greater risk of falling
Time frame: Baseline and four months
Total Daily Physical Activity
ActivPal Activity Monitors worn for a one week ambulatory monitoring period, counting number of steps
Time frame: Baseline and Four Months
Time Up and Go
Measures the time the participant takes to rise from a chair, walk 10 feet, turn around, walk back to the chair, and sit down
Time frame: Baseline and Four Months
6 Minute Walk Test
Distance walked in 6 minutes in meters
Time frame: Baseline and Four Months
Improved Balance as Measured by the Falls Efficacy
Falls Efficacy Scale as this is a widely-used measure among older adults that evaluates the fear of falling and balance confidence, 10-item questionnaire with scores ranging from minimum score 0 to maximum score 100. A total score of greater than 70 indicates that the person has a fear of falling
Time frame: Baseline and Four Months
| Milestone | High Intensity Walking | Casual Speed Walking |
|---|---|---|
| Started | 81 | 84 |
| Completed | 47 | 58 |
| Not completed | 34 | 26 |
Survey of Health Among Retired Europeans - Frailty Index (SHARE-FI) which assesses fatigue, appetite, weakness, walking difficulties, and low physical activity. There is not a max and min score; Higher scores indicate greater severity of frailty. Classification for Women: Non-frail: ≤0.315 Pre-frail: 0.316-2.130 Frail: ≥2.131 Classification for Men" Non-frail: ≤1.210 Pre-frail: 1.211-3.005 Frail: ≥3.006
| score on a scale | High Intensity Walking | Casual Speed Walking |
|---|---|---|
| Baseline | 2.10 ± 1.10 | 2.35 ± 1.20 |
| Four months | 0.61 ± 1.29 | 1.20 ± 1.47 |
Gait speed was measured independently as a continuous measure in meters per second (m/s). Participants completed two trials over 10 meters at both self-selected usual speed ("walk at your normal comfortable pace") and fastest-possible speed ("as fast as you safely can"), and the two trials were averaged for analysis.
| m/s | High Intensity Walking | Casual Speed Walking |
|---|---|---|
| Baseline | 0.80 ± 0.23 | 0.81 ± 0.21 |
| Four months | 0.89 ± 0.23 | 0.82 ± 0.20 |
The Short Physical Performance Battery is a scale to assess overall functional status and physical performance Min score = 0 Max score = 12 Higher scores = better physical function
| score on a scale | High Intensity Walking | Casual Speed Walking |
|---|---|---|
| Baseline | 6.74 ± 2.66 | 6.66 ± 2.69 |
| Four months | 7.74 ± 2.82 | 7.41 ± 2.63 |
The Berg Balance Scale is a valid and reliable 14 item tool to evaluate static and dynamic balance among older adults. Minimum Score: 0 to Maximum Score: 56 Score of \< 45 indicates individuals may be at greater risk of falling
| score on a scale | High Intensity Walking | Casual Speed Walking |
|---|---|---|
| Baseline | 42.00 (34.00 to 49.50) | 42.00 (37.00 to 48.00) |
| Four months | 46.00 (40.50 to 51.00) | 47.50 (43.00 to 51.00) |
ActivPal Activity Monitors worn for a one week ambulatory monitoring period, counting number of steps
| steps/day | High Intensity Walking | Casual Speed Walking |
|---|---|---|
| Baseline | 3699 ± 1810 | 3819 ± 2402 |
| Four months | 4195 ± 2108 | 3330 ± 1811 |
Measures the time the participant takes to rise from a chair, walk 10 feet, turn around, walk back to the chair, and sit down
| seconds | High Intensity Walking | Casual Speed Walking |
|---|---|---|
| Baseline | 16.56 (12.88 to 19.12) | 16.41 (13.17 to 20.09) |
| Four months | 13.85 (11.60 to 17.09) | 14.67 (12.85 to 18.55) |
Distance walked in 6 minutes in meters
| m | High Intensity Walking | Casual Speed Walking |
|---|---|---|
| Baseline | 262.14 ± 95.12 | 252.28 ± 82.97 |
| Four months | 317.48 ± 100.34 | 264.07 ± 97.40 |
Falls Efficacy Scale as this is a widely-used measure among older adults that evaluates the fear of falling and balance confidence, 10-item questionnaire with scores ranging from minimum score 0 to maximum score 100. A total score of greater than 70 indicates that the person has a fear of falling
| score on a scale | High Intensity Walking | Casual Speed Walking |
|---|---|---|
| Baseline | 18.57 ± 14.13 | 18.48 ± 13.07 |
| Four months | 17.68 ± 14.82 | 15.88 ± 7.99 |
Collected over Adverse event data were collected over the course of the 4 month intervention that each participant was enrolled in the study.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| High Intensity Walking | 0/81 (0%) | 4/81 (4.9%) | 7/81 (8.6%) |
| Casual Speed Walking | 0/84 (0%) | 9/84 (10.7%) | 2/84 (2.4%) |
| Event | High Intensity Walking | Casual Speed Walking |
|---|---|---|
| Muscle sorenessMusculoskeletal and connective tissue disorders | 3/81 | 9/84 |
| FallMusculoskeletal and connective tissue disorders | 1/81 | 0/84 |
| Event | High Intensity Walking | Casual Speed Walking |
|---|---|---|
| muscle sorenessMusculoskeletal and connective tissue disorders | 7/81 | 2/84 |
| Age, Continuous(years) | High Intensity Walking | Casual Speed Walking | Total |
|---|---|---|---|
| Mean | 79.2 ± 8.4 | 79.3 ± 7.8 | 79.2 ± 8.0 |
| Sex: Female, Male(Participants) | High Intensity Walking | Casual Speed Walking | Total |
|---|---|---|---|
| Female | 42 | 41 | 83 |
| Male | 5 | 17 | 22 |
| Race (NIH/OMB)(Participants) | High Intensity Walking | Casual Speed Walking | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 1 | 1 | 2 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 9 | 13 | 22 |
| White | 36 | 43 | 79 |
| More than one race | 0 | 0 | 0 |
| Unknown or Not Reported | 1 | 1 | 2 |
| Frail on the Survey of Health Among Retired Europeans - Frailty Index (SHARE-FI)(Participants) | High Intensity Walking | Casual Speed Walking | Total |
|---|---|---|---|
| Count of participants | 27 | 35 | 62 |
PDFs hosted by the registry, ClinicalTrials.gov.
Ran from Nov 2018 to primary completion in Jan 2023, 50 months.
Results were first posted in Nov 2026, 3 years 9 months after primary completion.
Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's 50 months is above that.
Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.